Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"A Randomized Controlled Trial of Rituximab Versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (IMN)"

NCT01180036 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT01180036
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01180036 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"A Randomized Controlled Trial of Rituximab Versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (IMN)"
Lead sponsor
Mayo Clinic
Phase
Phase 2/3
Overall status
Completed
Start date
November 30, 2011
Completion date
October 1, 2017
Enrollment
130 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic membranous nephropathy